Search - tctmd.com

Displaying 81 - 100 of 6830

Sort: Relevancy | Date

Presentation TCT 2025

An Algorithm for Managing Catastrophic Hypotension During TAVR

Presenter: James M. McCabe

October 28, 2025

Presentation TCT 2025

Paravalvular Leak Mitigation and Management

Presenter: Rahul Prakash Sharma

October 28, 2025

Presentation TCT 2025

Elevated Gradients Early After TAVR: HALT or PPM? Diagnosis and Management

Presenter: Amr E. Abbas

October 28, 2025

Presentation TCT 2025

TCT 849: Clinical and Economic Consequences of Delayed TAVR among Patients with Clinically Significant Aortic Senosis

Presenter: Curtiss T. Stinis

October 28, 2025

Presentation TCT 2025

Incidence and Clinical Consequences of Conduction Disturbances After TAVR

Presenter: Amit N. Vora

October 28, 2025

Presentation TCT 2025

Cerebral Embolic Protection Devices for Stroke Prevention: Is there Still a Role?

Presenter: Grant William Reed

October 28, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

TCT 766: Protamine At Reduced Dose For TAVR Anticoagulation Reversal

Presenter: Mohammed Ebrahim

October 27, 2025

Presentation TCT 2025

TCT 874: First-in-man Study of VitaFlow® III Controlled Bending Delivery System for Severe Aortic Stenosis: 30-Day Outcomes

Presenter: Yang Chen

October 27, 2025

Presentation TCT 2025

TCT 877: The PROVE registry: A prospective multi-center multi-national post-market registry of a short-frame supra-annular transcatheter aortic valve

Presenter: Oliver Dumpies

October 27, 2025

Presentation TCT 2025

TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

Presenter: Amer Hussein Muhyieddeen

October 27, 2025

Presentation TCT 2025

TCT 876: Anatomical and Procedural Predictors of Early Adverse Outcomes After Transcatheter Aortic Valve Replacement using Navitor in Bicuspid Aortic Valve. Insight from The International Navitor Bicuspid Registry.

Presenter: Sami Alnasser

October 27, 2025

Presentation TCT 2025

TCT 767: Clinical Outcomes of GLP-1 Receptor Agonist Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

Presenter: Amer Hussein Muhyieddeen

October 27, 2025

Presentation TCT 2025

TCT 875: Parametric Finite Element Modeling of Reinforced Polymeric Leaflets for Improved Durability

Presenter: SUSAN JAMES

October 27, 2025

Presentation TCT 2025

TCT 1402: Shear Consequences: A Case of Hemolytic Anemia From Paravalvular Leak Post-TAVR

Presenter: Benjamin Titus

October 27, 2025

Presentation TCT 2025

Procedural Planning for ViV TAVR

Presenter: Chad Alan Kliger

October 27, 2025

Presentation TCT 2025

TCT 1229: New-Onset Conduction Abnormalities Following Valve-in-Valve Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Judah Rajendran

October 27, 2025

Presentation TCT 2025

TCT 1225: Clinical Impact of Single- versus Multi-Access Technique for Valve-in-Valve Transcatheter Aortic Valve Replacement.

Presenter: Cesar Eduardo Soria Jimenez

October 27, 2025

Presentation TCT 2025

TCT 603: Performance of Aortic Valve Coefficient (AVC) in Relation with Calcium Score (CS) and Aortic Valve Area (AVA) in Patients Undergoing TAVR

Presenter: Rishi Sukhija

October 27, 2025

Presentation TCT 2025

TCT 1227: Redo-TAVR for Paravalvular Leak: Insight and Early Outcomes from Timing and Combinations

Presenter: Takayuki Onishi

October 27, 2025

Advertisement

An Algorithm for Managing Catastrophic Hypotension During TAVR

Paravalvular Leak Mitigation and Management

Elevated Gradients Early After TAVR: HALT or PPM? Diagnosis and Management

TCT 849: Clinical and Economic Consequences of Delayed TAVR among Patients with Clinically Significant Aortic Senosis

Incidence and Clinical Consequences of Conduction Disturbances After TAVR

Cerebral Embolic Protection Devices for Stroke Prevention: Is there Still a Role?

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

TCT 766: Protamine At Reduced Dose For TAVR Anticoagulation Reversal

TCT 874: First-in-man Study of VitaFlow® III Controlled Bending Delivery System for Severe Aortic Stenosis: 30-Day Outcomes

TCT 877: The PROVE registry: A prospective multi-center multi-national post-market registry of a short-frame supra-annular transcatheter aortic valve

TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

TCT 876: Anatomical and Procedural Predictors of Early Adverse Outcomes After Transcatheter Aortic Valve Replacement using Navitor in Bicuspid Aortic Valve. Insight from The International Navitor Bicuspid Registry.

TCT 767: Clinical Outcomes of GLP-1 Receptor Agonist Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

TCT 875: Parametric Finite Element Modeling of Reinforced Polymeric Leaflets for Improved Durability

TCT 1402: Shear Consequences: A Case of Hemolytic Anemia From Paravalvular Leak Post-TAVR

Procedural Planning for ViV TAVR

TCT 1229: New-Onset Conduction Abnormalities Following Valve-in-Valve Transcatheter Aortic Valve Replacement (TAVR)

TCT 1225: Clinical Impact of Single- versus Multi-Access Technique for Valve-in-Valve Transcatheter Aortic Valve Replacement.

TCT 603: Performance of Aortic Valve Coefficient (AVC) in Relation with Calcium Score (CS) and Aortic Valve Area (AVA) in Patients Undergoing TAVR

TCT 1227: Redo-TAVR for Paravalvular Leak: Insight and Early Outcomes from Timing and Combinations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content